Details of the Drug Metabolized by Drug-Metabolizing Enzyme (DME)
General Information of Drug (ID: DR1602) | ||||||
---|---|---|---|---|---|---|
Drug Name |
SR-4233
|
|||||
Synonyms |
SR 4233; SR-4233; SR4233; TIRAPAZAMINE; Tirapazamine [USAN:INN]; Tirazone; WIN 59075; Win-59075; 1,2,4-Benzotriazin-3-amine 1,4-Dioxide; 1,2,4-Benzotriazin-3-amine, 1,4-dioxide; 1,2,4-Benzotriazine, 3-amino-, 1,4-dioxide; 1,2,4-benzotriazin-3-amine,1,4-dioxide; 1UD32YR59G; 27314-97-2; 3-Amino-1,2,4-benzotriazine 1,4-dioxide; 3-Amino-1,2,4-benzotriazine-1,4-dioxide; 3-Aminobenzo[e][1,2,4]triazine 1,4-dioxide; 4-hydroxy-1-oxido-1,2,4-benzotriazin-1-ium-3-imine; BRN 0179322; C7H6N4O2; CHEBI:78887; NSC 130181; UNII-1UD32YR59G
|
|||||
Indication | Alzheimer disease [ICD11: 8A20] | Phase 3 | [1] | |||
Structure | ||||||
3D MOL | 2D MOL | |||||
Pharmaceutical Properties | Molecular Weight | 178.15 | Topological Polar Surface Area | 89.8 | ||
Heavy Atom Count | 13 | Rotatable Bond Count | 0 | |||
Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 4 | |||
Cross-matching ID | ||||||
The Metabolic Roadmap of This Drug | |||||
---|---|---|---|---|---|
The Full List of Drug Metabolites (DM) of This Drug | ||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
The Full List of Metabolic Reaction (MR) of This Drug | ||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
||||||||||||||||||||||||||||||||||||||||
Drug-Metabolizing Enzyme(s) (DME) Metabolizing This Drug | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.